Boris Kantor

Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD

Boris Kantor, Lidia Tagliafierro, Jeffrey Gu et al. · Molecular Therapy · 2018 · 198 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing

Pavel I. Ortinski, Bernadette O’Donovan, Xiaoyu Dong et al. · Molecular Therapy — Methods & Clinical Development · 2017 · 146 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release

Vladislav Temkin, Boris Kantor, Vivian B. Weg et al. · The Journal of Immunology · 2002 · 120 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Proteasome Inhibitors Enhance Gene Delivery by AAV Virus Vectors Expressing Large Genomes in Hemophilia Mouse and Dog Models: A Strategy for Broad Clinical Application

Paul E. Monahan, Clinton D. Lothrop, Junjiang Sun et al. · Molecular Therapy · 2010 · 119 citations · Full text

Pharmacy, Molecular Medicine, Translational Sciences +13

Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection

Boris Kantor, Hong Ma, Jennifer Webster‐Cyriaque et al. · Proceedings of the National Academy of Sciences · 2009 · 97 citations

Life Sciences, Microbiology, Molecular Biology +17